Search Results - "Ian Grieve"

An open-label, randomized study comparing lipegfilgrastim with filgrastim in pediatric patients receiving chemotherapy for Ewing sarcoma or rhabdomyosarcoma.

Authors: Belogurova, Margarita B. Lammerich, Andreas Barkay, Hadas et al.

Source: Scientific Reports. 11/12/2025, Vol. 15 Issue 1, p1-10. 10p.

Advancing Digital Solutions to Overcome Longstanding Barriers in Asthma and COPD Management.

Authors: Bosnic-Anticevich, Sinthia Bakerly, Nawar Diar Chrystyn, Henry et al.

Source: Patient Preference & Adherence. Jan2023, Vol. 17, p259-272. 14p.

Microsoft Dynamics GP 2016 Cookbook : Over 100 Powerful and Effective Recipes to Help You Solve Real-world Dynamics GP Problems

Authors: Mark Polino Ian Grieve

Resource Type: eBook.

Subjects: Accounting--Data processing, Accounting--Software

Categories: COMPUTERS / Business & Productivity Software / Project Management Tools, COMPUTERS / Business & Productivity Software / General, COMPUTERS / Business & Productivity Software / Collaboration

A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI.

Authors: Yun Kirby, Suyong Zhu, Chang-Qing Kerwin, Edward M. et al.

Source: COPD: Journal of Chronic Obstructive Pulmonary Disease. Apr2016, Vol. 13 Issue 2, p167-175. 9p.

4273π: Bioinformatics education on low cost ARM hardware.

Authors: Barker, Daniel Ferrier, David E. K. Holland, Peter W. H. et al.

Source: BMC Bioinformatics. 2013, Vol. 14 Issue 1, p1-6. 6p. 1 Color Photograph, 1 Chart.

Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study.

Authors: Robaeys, Geert Christensen, Stefan Lucidarme, Damien et al.

Source: Infectious Diseases & Therapy. Jun2017, Vol. 6 Issue 2, p265-275. 11p.

Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis.

Authors: El Raziky, M. Gamil, M. Ashour, M. K. et al.

Source: Journal of Viral Hepatitis. Feb2017, Vol. 24 Issue 2, p102-110. 9p.

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.

Authors: Asselah, Tarik Moreno, Christophe Sarrazin, Christoph et al.

Source: PLoS ONE. 1/5/2017, Vol. 12 Issue 1, p1-16. 16p.

An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1).

Authors: Asselah, Tarik Moreno, Christophe Sarrazin, Christoph et al.

Source: PLoS ONE. 7/18/2016, Vol. 11 Issue 7, p1-15. 15p.

Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin 5 monoclonal antibody, in healthy Japanese male subjects.

Authors: Tsukamoto, Naohiro Takahashi, Naoki Itoh, Hiroshi et al.

Source: Clinical Pharmacology in Drug Development. Mar/Apr2016, Vol. 5 Issue 2, p102-108. 7p.

Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial.

Authors: Ambery, Claire L. Wielders, Pascal Ludwig-Sengpiel, Andrea et al.

Source: Drugs in R&D. Sep2015, Vol. 15 Issue 3, p281-291. 11p.

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy.

Authors: Stynes, Gillian Svedsater, Henrik Jaro Wex et al.

Source: Respiratory Research. 2015, Vol. 16 Issue 2, p1-11. 11p. 1 Diagram, 2 Charts, 1 Graph.

Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation.

Authors: Ohar, Jill A. Crater, Glenn D. Emmett, Amanda et al.

Source: Respiratory Research. 2014, Vol. 15 Issue 9, p1-12. 12p. 2 Diagrams, 6 Charts, 3 Graphs.

Pharmacokinetics and pharmacodynamics of GSK961081, a novel inhaled muscarinic antagonist β2-agonist, and fluticasone propionate administered alone, concurrently and as a combination blend formulation in healthy volunteers.

Authors: Norris, Virginia Ambery, Claire Riley, Trevor

Source: Clinical Pharmacology in Drug Development. Jul2014, Vol. 3 Issue 4, p305-313. 9p.

Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study.

Authors: Allen, Ann Schenkenberger, Isabelle Trivedi, Roopa et al.

Source: Clinical Respiratory Journal. Oct2013, Vol. 7 Issue 4, p397-406. 10p.

Power plays.

Authors: Brasher, Stephen

Source: New Statesman; 8/23/2013, Vol. 142 Issue 5171, p16-16, 1/4p

Flirting with disaster.

Authors: Cooke, Rachel

Source: New Statesman; 3/27/2015, Vol. 144 Issue 5255, p85-85, 1p, 1 Illustration

An absorbing dress rehearsal for the back room deals ahead.

Authors: REVIEW ANDY McSMITH

Source: Independent (UK). 03/18/2015.

COALITION.

Source: Independent (UK). 03/29/2015.

Sustainable Water: Resources, Management and Challenges

Authors: Veera Gnaneswar Gude

Resource Type: eBook.

Subjects: Water reuse, Water resources development, Sustainable engineering, Water conservation, Water-supply engineering

Categories: TECHNOLOGY & ENGINEERING / Environmental / Water Supply